News

The Lubrizol Corporation has announced that the Contract Development and Manufacturing Organization (CDMO) Division of Lubrizol Life Science Health (LLS Health) is expanding its product development partnership with the Population Council, an international nongovernmental non-profit organization conducting research around...

Dyadic International, Inc. a leading biotechnology innovator focused on accelerating the development and lowering the manufacturing costs of vaccines and biopharmaceuticals, recently announced results which further support record expression levels of the SARS-CoV-2 Receptor Binding Domain (RBD) antigen produced...

Sirio Europe – the leading European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO), part of the Sirio group – announces the completion of a major overhaul of its Brandenburg site with advanced manufacturing and green technologies. The...

Russia announced that it has granted regulatory approval to another Covid-19 vaccine named EpiVacCorona. This comes after the country granted similar approval to Sputnik V, making it the first Covid-19 vaccine candidate in the world to attain regulatory approval. "I...

Innovative diagnostics company, Glyconics has won an £85,000 Phase 1 grant from the Global Challenges Research Fund (GCRF) to explore the feasibility of implementing a novel low-cost point-of-care diagnostic platform for diabetic screening in developing countries. Working in conjunction...

To date, all the major clinical trials of vaccines against COVID-19 have been in adults. Typically, Phase I safety trials were in healthy volunteers ages 18 to 55. Phase II and Phase III trials expanded that to include people...

The Hindustan Syringes & Medical Devices Ltd (HMD) has sent its first shipment of 56 million pieces of KOJAK Auto Disable Syringes to Covax facility as the race for a 'safe and effective' vaccine against coronavirus infection is on...